Repligen Corporation (RGEN)
USD 147.34
(-6.83%)
USD 147.34
(-6.83%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 54.57 Million USD | -52.62% |
| 2022 | 133.61 Million USD | 0.08% |
| 2021 | 133.49 Million USD | 213.81% |
| 2020 | 42.54 Million USD | 185.5% |
| 2019 | 14.9 Million USD | -42.66% |
| 2018 | 25.98 Million USD | 85.56% |
| 2017 | 14 Million USD | -12.33% |
| 2016 | 15.97 Million USD | 16.06% |
| 2015 | 13.76 Million USD | 28.74% |
| 2014 | 10.69 Million USD | -53.26% |
| 2013 | 22.87 Million USD | 106.38% |
| 2012 | 11.08 Million USD | 3062.84% |
| 2011 | -374.07 Thousand USD | 93.51% |
| 2010 | -5.76 Million USD | -248.63% |
| 2009 | 3.87 Million USD | -89.19% |
| 2008 | 35.89 Million USD | 2066.32% |
| 2007 | -1.82 Million USD | -49.63% |
| 2006 | -1.21 Million USD | 70.69% |
| 2005 | -4.16 Million USD | 58.14% |
| 2004 | -9.94 Million USD | -95.13% |
| 2003 | -5.09 Million USD | 8.67% |
| 2002 | -5.57 Million USD | 23.93% |
| 2001 | -7.33 Million USD | -88.48% |
| 2000 | -3.89 Million USD | -159.36% |
| 1999 | -1.5 Million USD | -87.5% |
| 1998 | -800 Thousand USD | -60.0% |
| 1997 | -500 Thousand USD | 93.59% |
| 1996 | -7.8 Million USD | 61.58% |
| 1995 | -20.3 Million USD | -5.73% |
| 1994 | -19.2 Million USD | -69.91% |
| 1993 | -11.3 Million USD | 11.72% |
| 1992 | -12.8 Million USD | -54.22% |
| 1991 | -8.3 Million USD | -232.0% |
| 1990 | -2.5 Million USD | 26.47% |
| 1989 | -3.4 Million USD | -209.09% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.45 Million USD | -26.78% |
| 2024 Q1 | 2.03 Million USD | 328.97% |
| 2023 FY | 63.3 Million USD | -52.62% |
| 2023 Q2 | 19.39 Million USD | -37.94% |
| 2023 Q4 | -887 Thousand USD | -118.45% |
| 2023 Q3 | 4.8 Million USD | -75.22% |
| 2023 Q1 | 31.25 Million USD | 76.24% |
| 2022 Q4 | 17.73 Million USD | -66.32% |
| 2022 FY | 133.61 Million USD | 0.08% |
| 2022 Q2 | 63.16 Million USD | 5.28% |
| 2022 Q1 | 60 Million USD | 60.29% |
| 2022 Q3 | 52.66 Million USD | -16.63% |
| 2021 Q1 | 36.38 Million USD | 108.87% |
| 2021 Q4 | 37.43 Million USD | -17.17% |
| 2021 Q3 | 45.19 Million USD | -6.31% |
| 2021 Q2 | 48.24 Million USD | 32.59% |
| 2021 FY | 133.49 Million USD | 213.81% |
| 2020 Q1 | 11.9 Million USD | 102.0% |
| 2020 Q4 | 17.41 Million USD | -16.9% |
| 2020 Q3 | 20.96 Million USD | 7.29% |
| 2020 FY | 42.54 Million USD | 185.5% |
| 2020 Q2 | 19.53 Million USD | 64.09% |
| 2019 Q2 | 11.05 Million USD | -1.05% |
| 2019 FY | 14.9 Million USD | -42.66% |
| 2019 Q1 | 11.17 Million USD | 42.25% |
| 2019 Q4 | 5.89 Million USD | -25.99% |
| 2019 Q3 | 7.96 Million USD | -27.95% |
| 2018 Q4 | 7.85 Million USD | -0.42% |
| 2018 FY | 25.98 Million USD | 85.56% |
| 2018 Q1 | 5.97 Million USD | 83.26% |
| 2018 Q2 | 4.27 Million USD | -28.5% |
| 2018 Q3 | 7.88 Million USD | 84.55% |
| 2017 Q1 | 5.67 Million USD | 95.39% |
| 2017 Q2 | 5.47 Million USD | -3.58% |
| 2017 Q3 | -406 Thousand USD | -107.42% |
| 2017 Q4 | 3.26 Million USD | 903.2% |
| 2017 FY | 14 Million USD | -12.33% |
| 2016 FY | 15.97 Million USD | 16.06% |
| 2016 Q1 | 3.46 Million USD | 142.51% |
| 2016 Q2 | 5.85 Million USD | 69.19% |
| 2016 Q3 | 3.74 Million USD | -36.05% |
| 2016 Q4 | 2.9 Million USD | -22.47% |
| 2015 Q3 | 3.68 Million USD | -19.98% |
| 2015 Q2 | 4.6 Million USD | 14.11% |
| 2015 Q4 | 1.42 Million USD | -61.28% |
| 2015 Q1 | 4.03 Million USD | 6505.44% |
| 2015 FY | 13.76 Million USD | 28.74% |
| 2014 Q3 | 2.21 Million USD | -28.64% |
| 2014 Q1 | 5.3 Million USD | 2.39% |
| 2014 Q2 | 3.1 Million USD | -41.49% |
| 2014 Q4 | 61.14 Thousand USD | -97.24% |
| 2014 FY | 10.69 Million USD | -53.26% |
| 2013 Q2 | 6.1 Million USD | 72.15% |
| 2013 Q4 | 5.18 Million USD | -35.54% |
| 2013 Q1 | 3.54 Million USD | -44.7% |
| 2013 FY | 22.87 Million USD | 106.38% |
| 2013 Q3 | 8.04 Million USD | 31.77% |
| 2012 Q3 | 2.18 Million USD | 66.02% |
| 2012 Q4 | 6.41 Million USD | 193.03% |
| 2012 Q1 | 1.16 Million USD | 0.0% |
| 2012 Q2 | 1.31 Million USD | 12.91% |
| 2012 FY | 11.08 Million USD | 3062.84% |
| 2011 FY | -374.07 Thousand USD | 93.51% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | -121.53 Thousand USD | 94.18% |
| 2011 Q1 | -2.08 Million USD | -802.99% |
| 2011 Q3 | 552.42 Thousand USD | 554.55% |
| 2010 Q3 | 526.53 Thousand USD | -40.78% |
| 2010 FY | -5.76 Million USD | -248.63% |
| 2010 Q4 | 296.8 Thousand USD | -43.63% |
| 2010 Q1 | -1.76 Million USD | -28.7% |
| 2010 Q2 | 889.09 Thousand USD | 150.44% |
| 2009 Q3 | -1.2 Million USD | 15.5% |
| 2009 Q1 | -3.21 Million USD | -497.56% |
| 2009 FY | 3.87 Million USD | -89.19% |
| 2009 Q2 | -1.42 Million USD | 55.6% |
| 2009 Q4 | -1.36 Million USD | -13.54% |
| 2008 Q2 | 7.95 Million USD | 305.94% |
| 2008 FY | 35.89 Million USD | 2066.32% |
| 2008 Q1 | -3.86 Million USD | -286.82% |
| 2008 Q3 | -324.51 Thousand USD | -104.08% |
| 2008 Q4 | -538.11 Thousand USD | -65.82% |
| 2007 FY | -1.82 Million USD | -49.63% |
| 2007 Q3 | -35.41 Million USD | -236998.53% |
| 2007 Q2 | -14.93 Thousand USD | 95.75% |
| 2007 Q4 | -999 Thousand USD | 97.18% |
| 2007 Q1 | -351.3 Thousand USD | -36.7% |
| 2006 Q4 | -256.98 Thousand USD | 76.55% |
| 2006 FY | -1.21 Million USD | 70.69% |
| 2006 Q1 | -1.01 Million USD | -149.65% |
| 2006 Q2 | -120.99 Thousand USD | 88.07% |
| 2006 Q3 | -1.09 Million USD | -805.88% |
| 2005 FY | -4.16 Million USD | 58.14% |
| 2005 Q4 | -406.24 Thousand USD | 40.24% |
| 2005 Q3 | -679.76 Thousand USD | -177.22% |
| 2005 Q2 | 880.28 Thousand USD | 260.31% |
| 2005 Q1 | -549.11 Thousand USD | 47.73% |
| 2004 Q2 | -741.73 Thousand USD | 77.88% |
| 2004 Q1 | -3.35 Million USD | -50.53% |
| 2004 Q3 | -1.81 Million USD | -145.37% |
| 2004 Q4 | -1.05 Million USD | 42.28% |
| 2004 FY | -9.94 Million USD | -95.13% |
| 2003 Q2 | -2.12 Million USD | -18.76% |
| 2003 FY | -5.09 Million USD | 8.67% |
| 2003 Q4 | -2.22 Million USD | 0.29% |
| 2003 Q3 | -2.23 Million USD | -5.08% |
| 2003 Q1 | -1.79 Million USD | -97.51% |
| 2002 Q4 | -906.33 Thousand USD | 26.81% |
| 2002 FY | -5.57 Million USD | 23.93% |
| 2002 Q1 | -1.13 Million USD | -5.43% |
| 2002 Q2 | -1.15 Million USD | -2.18% |
| 2002 Q3 | -1.23 Million USD | -6.77% |
| 2001 Q4 | -1.07 Million USD | 35.87% |
| 2001 Q3 | -1.67 Million USD | 0.54% |
| 2001 Q2 | -1.68 Million USD | 1.45% |
| 2001 Q1 | -1.71 Million USD | 19.48% |
| 2001 FY | -7.33 Million USD | -88.48% |
| 2000 Q3 | -1.76 Million USD | -18.87% |
| 2000 Q2 | -1.48 Million USD | -66.62% |
| 2000 FY | -3.89 Million USD | -159.36% |
| 2000 Q1 | -890.35 Thousand USD | 47.63% |
| 2000 Q4 | -2.12 Million USD | -20.59% |
| 1999 Q2 | -400 Thousand USD | 0.0% |
| 1999 FY | -1.5 Million USD | -87.5% |
| 1999 Q1 | -400 Thousand USD | 0.0% |
| 1999 Q4 | -1.7 Million USD | -112.5% |
| 1999 Q3 | -800 Thousand USD | -100.0% |
| 1998 Q2 | -400 Thousand USD | -33.33% |
| 1998 Q1 | -300 Thousand USD | -200.0% |
| 1998 Q3 | -200 Thousand USD | 50.0% |
| 1998 FY | -800 Thousand USD | -60.0% |
| 1998 Q4 | -400 Thousand USD | -100.0% |
| 1997 Q4 | -100 Thousand USD | 66.67% |
| 1997 Q3 | -300 Thousand USD | -200.0% |
| 1997 Q2 | -100 Thousand USD | 50.0% |
| 1997 Q1 | -200 Thousand USD | -100.0% |
| 1997 FY | -500 Thousand USD | 93.59% |
| 1996 FY | -7.8 Million USD | 61.58% |
| 1996 Q4 | -100 Thousand USD | -150.0% |
| 1996 Q3 | 200 Thousand USD | 140.0% |
| 1996 Q2 | -500 Thousand USD | 75.0% |
| 1996 Q1 | -2 Million USD | 13.04% |
| 1995 Q1 | -2.8 Million USD | 50.88% |
| 1995 FY | -20.3 Million USD | -5.73% |
| 1995 Q4 | -2.3 Million USD | -130.0% |
| 1995 Q3 | -1 Million USD | 61.54% |
| 1995 Q2 | -2.6 Million USD | 7.14% |
| 1994 FY | -19.2 Million USD | -69.91% |
| 1994 Q4 | -5.7 Million USD | 3.39% |
| 1994 Q2 | -5.9 Million USD | -28.26% |
| 1994 Q1 | -4.6 Million USD | 13.21% |
| 1994 Q3 | -5.9 Million USD | 0.0% |
| 1993 Q3 | -4.6 Million USD | 9.8% |
| 1993 Q4 | -5.3 Million USD | -15.22% |
| 1993 Q2 | -5.1 Million USD | -2450.0% |
| 1993 Q1 | -200 Thousand USD | 96.55% |
| 1993 FY | -11.3 Million USD | 11.72% |
| 1992 Q3 | -4.7 Million USD | -1275.0% |
| 1992 Q4 | -5.8 Million USD | -23.4% |
| 1992 FY | -12.8 Million USD | -54.22% |
| 1992 Q1 | -800 Thousand USD | 90.48% |
| 1992 Q2 | 400 Thousand USD | 150.0% |
| 1991 Q2 | -1.4 Million USD | 65.85% |
| 1991 Q1 | -4.1 Million USD | -173.33% |
| 1991 FY | -8.3 Million USD | -232.0% |
| 1991 Q3 | -2.2 Million USD | -57.14% |
| 1991 Q4 | -8.4 Million USD | -281.82% |
| 1990 Q2 | -1.3 Million USD | 88.07% |
| 1990 Q4 | -1.5 Million USD | -7.14% |
| 1990 FY | -2.5 Million USD | 26.47% |
| 1990 Q3 | -1.4 Million USD | -7.69% |
| 1990 Q1 | -10.9 Million USD | -402.78% |
| 1989 FY | -3.4 Million USD | -209.09% |
| 1989 Q4 | 3.6 Million USD | 33.33% |
| 1989 Q3 | 2.7 Million USD | 8.0% |
| 1989 Q2 | 2.5 Million USD | 125.77% |
| 1989 Q1 | -9.7 Million USD | -459.26% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 194.638% |
| AngioDynamics, Inc. | -97.71 Million USD | 155.851% |
| AtriCure, Inc. | -26.68 Million USD | 304.535% |
| Avinger, Inc. | -16.63 Million USD | 428.079% |
| Azenta, Inc. | -73.12 Million USD | 174.633% |
| BioLife Solutions, Inc. | -70.82 Million USD | 177.058% |
| The Cooper Companies, Inc. | 533.1 Million USD | 89.763% |
| Daxor Corporation | -177.07 Thousand USD | 30920.839% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 461.143% |
| Femasys Inc. | -14.5 Million USD | 476.168% |
| GlucoTrack, Inc. | -7.1 Million USD | 868.243% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -2781.521% |
| Hologic, Inc. | 882.6 Million USD | 93.816% |
| ICU Medical, Inc. | 22.82 Million USD | -139.106% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 96.911% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 631.413% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | -47.177% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 890.894% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 890.894% |
| Masimo Corporation | 136.5 Million USD | 60.018% |
| Microbot Medical Inc. | -9.85 Million USD | 653.79% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | -271.899% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 55.967% |
| Nephros, Inc. | -1.59 Million USD | 3525.989% |
| NovoCure Limited | -232.87 Million USD | 123.436% |
| NEXGEL, Inc. | -3.47 Million USD | 1669.629% |
| NEXGEL, Inc. | -3.47 Million USD | 1669.629% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 153.089% |
| OraSure Technologies, Inc. | 54.07 Million USD | -0.919% |
| Pro-Dex, Inc. | 7.17 Million USD | -660.853% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 225.249% |
| Predictive Oncology Inc. | -13.92 Million USD | 492.032% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 2103.279% |
| QuidelOrtho Corporation | 139.1 Million USD | 60.765% |
| Sanara MedTech Inc. | -4.21 Million USD | 1394.757% |
| STAAR Surgical Company | 28.09 Million USD | -94.241% |
| Sharps Technology, Inc. | -10.12 Million USD | 638.934% |
| Utah Medical Products, Inc. | 16.77 Million USD | -225.302% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 164.207% |
| Jin Medical International Ltd. | 2.86 Million USD | -1803.419% |